Recent advances in therapeutic approaches for adult T-cell leukemia/lymphoma

Viruses

Volumn 7, Issue 12, 2015, Pages 6604-6612

  Kato, Koji ^a   Akashi, Koichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Adult T cell leukemia lymphoma; Allogeneic hematopoietic stem cell transplantation; Antiviral therapy; Chemotherapy; Graft versus host disease; Mogamulizumab

Indexed keywords

ALPHA INTERFERON; BORTEZOMIB; BRENTUXIMAB VEDOTIN; CARBOPLATIN; CYCLOPHOSPHAMIDE; DENILEUKIN DIFTITOX; DOXORUBICIN; ETOPOSIDE; FORODESINE; IMMUNOSUPPRESSIVE AGENT; LENALIDOMIDE; MOGAMULIZUMAB; PANOBINOSTAT; PRALATREXATE; PREDNISOLONE; RANIMUSTINE; VINCRISTINE; VINDESINE; ZIDOVUDINE; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIVIRAL THERAPY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL TRIAL (TOPIC); HUMAN; META ANALYSIS (TOPIC); MOLECULARLY TARGETED THERAPY; MULTICENTER STUDY (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; T CELL LEUKEMIA; ADULT; ALLOTRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MULTIMODALITY CANCER THERAPY; PROCEDURES; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; COMBINED MODALITY THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84949968907     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v7122960     Document Type: Review

References (50)

1. Uchiyama, T.; Yodoi, J.; Sagawa, K.; Takatsuki, K.; Uchino, H. Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood 1977, 50, 481–492. [CrossRef]
2. Poiesz, B.J.; Ruscetti, F.W.; Gazdar, A.F.; Bunn, P.A.; Minna, J.D.; Gallo, R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 1980, 77, 7415–7419. [CrossRef] [PubMed]
3. Osame, M.; Izumo, S.; Igata, A.; Matsumoto, M.; Matsumoto, T.; Sonoda, S.; Tara, M.; Shibata, Y. Blood transfusion and HTLV-I associated myelopathy. Lancet 1986, 2, 104–105. [CrossRef]
4. Laydon, D.J.; Melamed, A.; Sim, A.; Gillet, N.A.; Sim, K.; Darko, S.; Kroll, J.S.; Douek, D.C.; Price, D.A.; Bangham, C.R.; Asquith, B. Quantification of HTLV-1 clonality and TCR diversity. PLoS Comput. Biol. 2014, 10, e1003646. [CrossRef] [PubMed]
5. Shimoyama, M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984–87). Br. J. Haematol. 1991, 79, 428–437. [CrossRef] [PubMed]
6. Takasaki, Y.; Iwanaga, M.; Imaizumi, Y.; Tawara, M.; Joh, T.; Kohno, T.; Yamada, Y.; Kamihira, S.; Ikeda, S.; Miyazaki, Y., et al. Long-term study of indolent adult T-cell leukemia-lymphoma. Blood 2010, 115, 4337–4343. [CrossRef] [PubMed]
7. Katsuya, H.; Yamanaka, T.; Ishitsuka, K.; Utsunomiya, A.; Sasaki, H.; Hanada, S.; Eto, T.; Moriuchi, Y.; Saburi, Y.; Miyahara, M., et al. Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma. J. Clin. Oncol. 2012, 30, 1635–1640. [CrossRef] [PubMed]
8. Fukushima, T.; Nomura, S.; Shimoyama, M.; Shibata, T.; Imaizumi, Y.; Moriuchi, Y.; Tomoyose, T.; Uozumi, K.; Kobayashi, Y.; Fukushima, N., et al. Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A). Br. J. Haematol. 2014, 166, 739–748. [CrossRef] [PubMed]
9. Ishitsuka, K.; Tamura, K. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet Oncol. 2014, 15, e517–e526. [CrossRef]
10. Utsunomiya, A.; Choi, I.; Chihara, D.; Seto, M. Recent advances in the treatment of adult T-cell leukemia-lymphomas. Cancer Sci. 2015, 106, 344–351. [CrossRef] [PubMed]
11. Bazarbachi, A.; Suarez, F.; Fields, P.; Hermine, O. How I treat adult T-cell leukemia/lymphoma. Blood 2011, 118, 1736–1745. [CrossRef] [PubMed]
12. Hermine, O.; Bouscary, D.; Gessain, A.; Turlure, P.; Leblond, V.; Franck, N.; Buzyn-Veil, A.; Rio, B.; Macintyre, E.; Dreyfus, F., et al. Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N. Engl. J. Med. 1995, 332, 1749–1751. [CrossRef] [PubMed]
13. Tsukasaki, K.; Hermine, O.; Bazarbachi, A.; Ratner, L.; Ramos, J.C.; Harrington, W., Jr.; O’Mahony, D.; Janik, J.E.; Bittencourt, A.L.; Taylor, G.P., et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J. Clin. Oncol. 2009, 27, 453–459. [CrossRef] [PubMed]
14. Bazarbachi, A.; Plumelle, Y.; Carlos Ramos, J.; Tortevoye, P.; Otrock, Z.; Taylor, G.; Gessain, A.; Harrington, W.; Panelatti, G.; Hermine, O. Meta-analysis on the use of zidovudine and interferon-a in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. J. Clin. Oncol. 2010, 28, 4177–4183. [CrossRef] [PubMed]
15. Ratner, L.; Harrington, W.; Feng, X.; Grant, C.; Jacobson, S.; Noy, A.; Sparano, J.; Lee, J.; Ambinder, R.; Campbell, N., et al. Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma. PLoS ONE 2009, 4, e4420. [CrossRef] [PubMed]
16. Yamada, Y.; Tomonaga, M.; Fukuda, H.; Hanada, S.; Utsunomiya, A.; Tara, M.; Sano, M.; Ikeda, S.; Takatsuki, K.; Kozuru, M., et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan CLINICAL ONCOLOGY GROUP STUDY 9303. Br. J. Haematol. 2001, 113, 375–382. [CrossRef] [PubMed]
17. Tsukasaki, K.; Utsunomiya, A.; Fukuda, H.; Shibata, T.; Fukushima, T.; Takatsuka, Y.; Ikeda, S.; Masuda, M.; Nagoshi, H.; Ueda, R., et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J. Clin. Oncol. 2007, 25, 5458–5464. [CrossRef] [PubMed]
18. Tsukasaki, K.; Maeda, T.; Arimura, K.; Taguchi, J.; Fukushima, T.; Miyazaki, Y.; Moriuchi, Y.; Kuriyama, K.; Yamada, Y.; Tomonaga, M. Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: A case report and review of the literature. Bone Marrow Transpl. 1999, 23, 87–89. [CrossRef] [PubMed]
19. Utsunomiya, A.; Miyazaki, Y.; Takatsuka, Y.; Hanada, S.; Uozumi, K.; Yashiki, S.; Tara, M.; Kawano, F.; Saburi, Y.; Kikuchi, H., et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl. 2001, 27, 15–20. [CrossRef] [PubMed]
20. Kami, M.; Hamaki, T.; Miyakoshi, S.; Murashige, N.; Kanda, Y.; Tanosaki, R.; Takaue, Y.; Taniguchi, S.; Hirai, H.; Ozawa, K., et al. Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma. Br. J. Haematol. 2003, 120, 304–309. [CrossRef] [PubMed]
21. Fukushima, T.; Miyazaki, Y.; Honda, S.; Kawano, F.; Moriuchi, Y.; Masuda, M.; Tanosaki, R.; Utsunomiya, A.; Uike, N.; Yoshida, S., et al. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma. Leukemia 2005, 19, 829–834. [CrossRef] [PubMed]
22. Kato, K.; Kanda, Y.; Eto, T.; Muta, T.; Gondo, H.; Taniguchi, S.; Shibuya, T.; Utsunomiya, A.; Kawase, T.; Kato, S., et al. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: Retrospective analysis of data from the Japan Marrow Donor Program. Biol. Blood Marrow Transpl. 2007, 13, 90–99. [CrossRef] [PubMed]
23. Nakase, K.; Hara, M.; Kozuka, T.; Tanimoto, K.; Nawa, Y. Bone marrow transplantation from unrelated donors for patients with adult T-cell leukaemia/lymphoma. Bone Marrow Transpl. 2006, 37, 41–44. [CrossRef] [PubMed]
24. Shiratori, S.; Yasumoto, A.; Tanaka, J.; Shigematsu, A.; Yamamoto, S.; Nishio, M.; Hashino, S.; Morita, R.; Takahata, M.; Onozawa, M., et al. A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): Clinical impact of graft-versus-leukemia/lymphoma effect. Biol. Blood Marrow Transpl. 2008, 14, 817–823. [CrossRef] [PubMed]
25. Takizawa, J.; Aoki, S.; Kurasaki, T.; Higashimura, M.; Honma, K.; Kitajima, T.; Momoi, A.; Takahashi, H.; Nakamura, N.; Furukawa, T., et al. Successful treatment of adult T-cell leukemia with unrelated cord blood transplantation. Am. J. Hematol. 2007, 82, 1113–1115. [CrossRef] [PubMed]
26. Ishida, T.; Hishizawa, M.; Kato, K.; Tanosaki, R.; Fukuda, T.; Taniguchi, S.; Eto, T.; Takatsuka, Y.; Miyazaki, Y.; Moriuchi, Y., et al. Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: A nationwide retrospective study. Blood 2012, 120, 1734–1741. [CrossRef] [PubMed]
27. Hishizawa, M.; Kanda, J.; Utsunomiya, A.; Taniguchi, S.; Eto, T.; Moriuchi, Y.; Tanosaki, R.; Kawano, F.; Miyazaki, Y.; Masuda, M., et al. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: A nationwide retrospective study. Blood 2010, 116, 1369–1376. [CrossRef] [PubMed]
28. Kato, K.; Choi, I.; Wake, A.; Uike, N.; Taniguchi, S.; Moriuchi, Y.; Miyazaki, Y.; Nakamae, H.; Oku, E.; Murata, M., et al. Treatment of patients with adult T cell leukemia/lymphoma with cord blood transplantation: A Japanese nationwide retrospective survey. Biol. Blood Marrow Transpl. 2014, 20, 1968–1974. [CrossRef] [PubMed]
29. Fukushima, T.; Itonaga, H.; Moriuchi, Y.; Yoshida, S.; Taguchi, J.; Imaizumi, Y.; Imanishi, D.; Tsushima, H.; Sawayama, Y.; Matsuo, E., et al. Feasibility of cord blood transplantation in chemosensitive adult T-cell leukemia/lymphoma: A retrospective analysis of the Nagasaki Transplantation Network. Int J. Hematol. 2013, 97, 485–490. [CrossRef] [PubMed]
30. Nakamura, T.; Oku, E.; Nomura, K.; Morishige, S.; Takata, Y.; Seki, R.; Imamura, R.; Osaki, K.; Hashiguchi, M.; Yakushiji, K., et al. Unrelated cord blood transplantation for patients with adult T-cell leukemia/lymphoma: experience at a single institute. Int. J. Hematol. 2012, 96, 657–663. [CrossRef] [PubMed]
31. Bazarbachi, A.; Cwynarski, K.; Boumendil, A.; Finel, H.; Fields, P.; Raj, K.; Nagler, A.; Mohty, M.; Sureda, A.; Dreger, P., et al. Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: A retrospective study by the EBMT LWP. Bone Marrow Transpl. 2014, 49, 1266–1268. [CrossRef] [PubMed]
32. Okamura, J.; Utsunomiya, A.; Tanosaki, R.; Uike, N.; Sonoda, S.; Kannagi, M.; Tomonaga, M.; Harada, M.; Kimura, N.; Masuda, M., et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma. Blood 2005, 105, 4143–4145. [CrossRef] [PubMed]
33. Choi, I.; Tanosaki, R.; Uike, N.; Utsunomiya, A.; Tomonaga, M.; Harada, M.; Yamanaka, T.; Kannagi, M.; Okamura, J. Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: Results of prospective trials. Bone Marrow Transpl. 2011, 46, 116–118. [CrossRef] [PubMed]
34. Yamamoto, K.; Utsunomiya, A.; Tobinai, K.; Tsukasaki, K.; Uike, N.; Uozumi, K.; Yamaguchi, K.; Yamada, Y.; Hanada, S.; Tamura, K., et al. Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J. Clin. Oncol. 2010, 28, 1591–1598. [CrossRef] [PubMed]
35. Ishida, T.; Joh, T.; Uike, N.; Yamamoto, K.; Utsunomiya, A.; Yoshida, S.; Saburi, Y.; Miyamoto, T.; Takemoto, S.; Suzushima, H., et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: A multicenter phase II study. J. Clin. Oncol. 2012, 30, 837–842. [CrossRef] [PubMed]
36. Ishida, T.; Jo, T.; Takemoto, S.; Suzushima, H.; Uozumi, K.; Yamamoto, K.; Uike, N.; Saburi, Y.; Nosaka, K.; Utsunomiya, A., et al. Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: A randomized phase II study. Br. J. Haematol. 2015, 169, 672–682. [CrossRef] [PubMed]
37. Ishida, T.; Ito, A.; Sato, F.; Kusumoto, S.; Iida, S.; Inagaki, H.; Morita, A.; Akinaga, S.; Ueda, R. Stevens-Johnson Syndrome associated with mogamulizumab treatment of adult T-cell leukemia/lymphoma. Cancer Sci. 2013, 104, 647–650. [CrossRef] [PubMed]
38. Kato, K.; Miyamoto, T.; Numata, A.; Nakaike, T.; Oka, H.; Yurino, A.; Kuriyama, T.; Mori, Y.; Yamasaki, S.; Muta, T., et al. Diffuse panbronchiolitis after humanized anti-CCR4 monoclonal antibody therapy for relapsed adult T-cell leukemia/lymphoma. Int. J. Hematol. 2013, 97, 430–432. [CrossRef] [PubMed]
39. Ishitsuka, K.; Murahashi, M.; Katsuya, H.; Mogi, A.; Masaki, M.; Kawai, C.; Goto, T.; Ishizu, M.; Ikari, Y.; Takamatsu, Y., et al. Colitis mimicking graft-versus-host disease during treatment with the anti-CCR4 monoclonal antibody, mogamulizumab. Int. J. Hematol. 2015, 102, 493–497. [CrossRef] [PubMed]
40. Ito, Y.; Miyamoto, T.; Chong, Y.; Aoki, T.; Kato, K.; Akashi, K.; Kamimura, T. Successful treatment with anti-CC chemokine receptor 4 MoAb of relapsed adult T-cell leukemia/lymphoma after umbilical cord blood transplantation. Bone Marrow Transpl. 2013, 48, 998–999. [CrossRef] [PubMed]
41. Motohashi, K.; Suzuki, T.; Kishimoto, K.; Numata, A.; Nakajima, Y.; Tachibana, T.; Ohshima, R.; Kuwabara, H.; Tanaka, M.; Tomita, N., et al. Successful treatment of a patient with adult T cell leukemia/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation. Int. J. Hematol. 2013, 98, 258–260. [CrossRef] [PubMed]
42. Ishitsuka, K.; Utsunomiya, A.; Katsuya, H.; Takeuchi, S.; Takatsuka, Y.; Hidaka, M.; Sakai, T.; Yoshimitsu, M.; Ishida, T.; Tamura, K. A phase II study of bortezomib in patients with relapsed or refractory aggressive adult T-cell leukemia/lymphoma. Cancer Sci. 2015, 106, 1219–1223. [CrossRef] [PubMed]
43. Yonekura, K.; Utsunomiya, A.; Takatsuka, Y.; Takeuchi, S.; Tashiro, Y.; Kanzaki, T.; Kanekura, T. Graft-versus-adult T-cell leukemia/lymphoma effect following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl. 2008, 41, 1029–1035. [CrossRef] [PubMed]
44. Kanda, J.; Hishizawa, M.; Utsunomiya, A.; Taniguchi, S.; Eto, T.; Moriuchi, Y.; Tanosaki, R.; Kawano, F.; Miyazaki, Y.; Masuda, M., et al. Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study. Blood 2012, 119, 2141–2148. [CrossRef] [PubMed]
45. Kamimura, T.; Miyamoto, T.; Kawano, N.; Numata, A.; Ito, Y.; Chong, Y.; Nagafuji, K.; Teshima, T.; Hayashi, S.; Akashi, K. Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation. Int. J. Hematol. 2012, 95, 725–730. [CrossRef] [PubMed]
46. Itonaga, H.; Tsushima, H.; Taguchi, J.; Fukushima, T.; Taniguchi, H.; Sato, S.; Ando, K.; Sawayama, Y.; Matsuo, E.; Yamasaki, R., et al. Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: The Nagasaki Transplant Group experience. Blood 2013, 121, 219–225. [CrossRef] [PubMed]
47. Harashima, N.; Kurihara, K.; Utsunomiya, A.; Tanosaki, R.; Hanabuchi, S.; Masuda, M.; Ohashi, T.; Fukui, F.; Hasegawa, A.; Masuda, T., et al. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res. 2004, 64, 391–399. [CrossRef] [PubMed]
48. Tamai, Y.; Hasegawa, A.; Takamori, A.; Sasada, A.; Tanosaki, R.; Choi, I.; Utsunomiya, A.; Maeda, Y.; Yamano, Y.; Eto, T., et al. Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantation. J. Immunol. 2013, 190, 4382–4392. [CrossRef] [PubMed]
49. Suehiro, Y.; Hasegawa, A.; Iino, T.; Sasada, A.; Watanabe, N.; Matsuoka, M.; Takamori, A.; Tanosaki, R.; Utsunomiya, A.; Choi, I., et al. Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study. Br. J. Haematol. 2015, 169, 356–367. [CrossRef] [PubMed]
50. Itonaga, H.; Taguchi, J.; Fukushima, T.; Tsushima, H.; Sato, S.; Ando, K.; Sawayama, Y.; Matsuo, E.; Yamasaki, R.; Onimaru, Y., et al. Distinct clinical features of infectious complications in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation: A retrospective analysis in the Nagasaki transplant group. Biol. Blood Marrow Transpl. 2013, 19, 607–615. [CrossRef] [PubMed]